Mariarosaria Del Sorbo

Via Di Castel Romano 100
Rome, 00128, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors.

Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors.

Journal: Molecular therapy. Oncology

Published: May 23, 2023

MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans.

MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans.

Journal: Science translational medicine

Published: October 08, 2019

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection.

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection.

Journal: Frontiers in immunology

Published: July 25, 2018

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.

Journal: The Journal of infectious diseases

Published: July 02, 2018

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.

Journal: Vaccines

Published: June 07, 2016

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.

Journal: Science translational medicine

Published: August 14, 2015

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.

Journal: Hepatology (Baltimore, Md.)

Published: July 22, 2015

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates.

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates.

Journal: Molecular therapy. Methods & clinical development

Published: February 17, 2015

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

Journal: Science translational medicine

Published: November 08, 2014

Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial.

Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial.

Journal: PloS one

Published: April 01, 2014

Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.

Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 19, 2013

Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.

Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.

Journal: Clinical and vaccine immunology : CVI

Published: March 24, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026